Stay updated on Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding lapse notice and confirms the NIH Clinical Center is open, with status sources listed, and a version upgrade to v3.2.0.
    Difference
    8%
    Check dated 2025-10-05T14:26:04.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T09:46:28.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2; Back to Top element removed. Core content and key data remain unchanged.
    Difference
    0.5%
    Check dated 2025-09-14T00:16:03.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.5%
    Check dated 2025-09-06T21:04:45.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. These changes enhance the clarity and relevance of the page's content.
    Difference
    76%
    Check dated 2025-08-30T15:27:34.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T11:45:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.